Literature DB >> 21382536

The expression and assessment of emotions and internal states in individuals with severe or profound intellectual disabilities.

Dawn Adams1, Chris Oliver.   

Abstract

The expression of emotions and internal states by individuals with severe or profound intellectual disabilities is a comparatively under-researched area. Comprehensive or standardized methods of assessing or understanding the emotions and internal states within this population, whose ability to communicate is significantly compromised, do not exist. The literature base will be discussed and compared to that applicable to the general population. Methods of assessing broader internal states, notably depression, anxiety, and pain within severe or profound intellectual disabilities are also addressed. Finally, this review will examine methods of assessing internal states within genetic syndromes, including hunger, social anxiety, and happiness within Prader-Willi, Fragile-X and Angelman syndrome. This will allow for identification of robust methodologies used in assessing the expression of these internal states, some of which may be useful when considering how to assess emotions within individuals with intellectual disabilities. Crown
Copyright © 2011. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21382536     DOI: 10.1016/j.cpr.2011.01.003

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  11 in total

1.  Brief Report: A Longitudinal Study of Excessive Smiling and Laughing in Children with Angelman Syndrome.

Authors:  Dawn Adams; Kate Horsler; Rebecca Mount; Chris Oliver
Journal:  J Autism Dev Disord       Date:  2015-08

2.  Enhanced Nociception in Angelman Syndrome Model Mice.

Authors:  Eric S McCoy; Bonnie Taylor-Blake; Megumi Aita; Jeremy M Simon; Benjamin D Philpot; Mark J Zylka
Journal:  J Neurosci       Date:  2017-09-20       Impact factor: 6.167

3.  Identification of emotions and physiological response in individuals with moderate intellectual disability.

Authors:  Agustín Ernesto Martínez-González; Alejandro Veas
Journal:  Int J Dev Disabil       Date:  2019-08-27

4.  Utilising Interview Methodology to Inform the Development of New Clinical Assessment Tools for Anxiety in Autistic Individuals Who Speak Few or no Words.

Authors:  Georgina Edwards; Joanne Tarver; Lauren Shelley; Megan Bird; Jessica Hughes; Hayley Crawford; Jane Waite
Journal:  J Autism Dev Disord       Date:  2022-03-18

5.  Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study.

Authors:  Elise Ng-Cordell; Anna Kolesnik-Taylor; Sinéad O'Brien; Duncan Astle; Gaia Scerif; Kate Baker
Journal:  J Autism Dev Disord       Date:  2022-05-10

6.  Troubled sleep: A response to commentaries.

Authors:  David Haig
Journal:  Evol Med Public Health       Date:  2014-03-14

7.  Deep Assessment: A Novel Framework for Improving the Care of People with Very Advanced Alzheimer's Disease.

Authors:  Gordon Lyons; Michael Arthur-Kelly; Ami Eidels; Aimee Mavratzakis
Journal:  Biomed Res Int       Date:  2015-11-24       Impact factor: 3.411

8.  Potential and Pitfalls of Digital Voice Assistants in Older Adults With and Without Intellectual Disabilities: Relevance of Participatory Design Elements and Ecologically Valid Field Studies.

Authors:  Anna Schlomann; Hans-Werner Wahl; Peter Zentel; Vera Heyl; Leonore Knapp; Christiane Opfermann; Torsten Krämer; Christian Rietz
Journal:  Front Psychol       Date:  2021-07-01

Review 9.  Recognition of facial expressions by alcoholic patients: a systematic literature review.

Authors:  Mariana Fortunata Donadon; Flávia de Lima Osório
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-05       Impact factor: 2.570

10.  Biomusic: An Auditory Interface for Detecting Physiological Indicators of Anxiety in Children.

Authors:  Stephanie Cheung; Elizabeth Han; Azadeh Kushki; Evdokia Anagnostou; Elaine Biddiss
Journal:  Front Neurosci       Date:  2016-08-30       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.